By activating both glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptors, it boosts insulin secretion and enhances appetite suppression, often leading to even greater weight loss (Jastreboff et al., 2022)
Plan sponsors have struggled with managing the high costs of GLP-1s, with some restricting coverage or shifting coverage off pharmacy to the medical benefit to save costs
Frequently Asked Questions GLP-1 medications are highly effective at reducing appetite and supporting weight loss, but they work best when combined with intentional nutrition support
GLP-1 injections increase insulin secretion in response to food intake and help the body use insulin more effectively
We utilize small-batch synthesis, which gives us meticulous control over the entire process, ensuring the final product is exactly what it's supposed to be
Responders exhibited significantly elevated post-treatment serum lipid peroxidation (4-hydroxynonenal, 4-HNE) levels compared to non-responders, confirming on-target induction of ferroptosis